Boston Partners

Institutional investor · Portfolio as of Q4 2019

Top Holdings707 positions

Checking export access…
Activity:
BAC

Bank of America Corporation

50.2M$1.8B2.3%$20.82+43.70%
5 qtrssince 2018-Q4
Increased
54
BRK/B

Berkshire Hathaway Inc.

7.5M$1.7B2.2%$204.63+10.69%
5 qtrssince 2018-Q4
Decreased
0
JPM

JPMorgan Chase & Co.

10.2M$1.4B1.9%$92.58+25.19%
5 qtrssince 2018-Q4
Increased
50
C

Citigroup, Inc.

16M$1.3B1.7%$40.93+53.76%
5 qtrssince 2018-Q4
Increased
53
WFC

Wells Fargo & Company

20.4M$1.1B1.5%$37.66+20.41%
5 qtrssince 2018-Q4
Decreased
0
MPC

Marathon Petroleum Corporation

17M$1B1.4%$47.73+3.50%
5 qtrssince 2018-Q4
Increased
64
CI

The Cigna Group

4.9M$997.4M1.3%$163.00+12.84%
5 qtrssince 2018-Q4
Decreased
0
CMCSA

Comcast Corporation

21.5M$968.8M1.3%$25.70+32.38%
5 qtrssince 2018-Q4
Decreased
0
MDT

Medtronic plc.

8.3M$941.3M1.2%$73.85+26.00%
5 qtrssince 2018-Q4
Decreased
0
CB

Chubb Limited

5.8M$909.3M1.2%$116.20+20.61%
5 qtrssince 2018-Q4
Decreased
0
VLO

Valero Energy Corporation

9.7M$906.5M1.2%$66.72+8.27%
5 qtrssince 2018-Q4
Increased
65
PFE

Pfizer, Inc.

22.7M$890.1M1.2%$28.56-6.82%
5 qtrssince 2018-Q4
Increased
51
5.9M$878.3M1.2%——
5 qtrssince 2018-Q4
Decreased
0
GOOGL

Alphabet Inc.

637,183$853.6M1.1%$54.97+20.69%
5 qtrssince 2018-Q4
Decreased
0
DOV

Dover Corporation

7.4M$850.8M1.1%$68.62+53.95%
5 qtrssince 2018-Q4
Decreased
0
VZ

Verizon Communications Inc.

13.8M$846.8M1.1%$36.07+13.32%
5 qtrssince 2018-Q4
Decreased
0
AIG

American International Group, Inc.

16.3M$834.6M1.1%$32.81+31.31%
5 qtrssince 2018-Q4
Decreased
0
PG

The Procter & Gamble Company

6.5M$809.3M1.1%$75.20+38.99%
5 qtrssince 2018-Q4
Decreased
0
KSU

KANSAS CITY SOUTHERN

4.8M$742.8M1.0%——
4 qtrssince 2019-Q1
Decreased
0
TFC

Truist Financial Corporation

13M$734.9M1.0%$41.400.00%
1 qtr
New
62
$75.6B
AUM
707
Positions
Q4 2019
Filing
HI rating · 3.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2019-Q1$75,477,066,0008.45301706813%
2019-Q2$76,251,453,0001.02598980199%
2019-Q3$73,847,162,000-3.15310843978%
2019-Q4$75,607,758,0002.38410786863%
Activity profile
$ moved · Q4'19
New11%Increased35%Decreased46%Exited8%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.3 quarters
<1Q7%1-4Q21%1-2Y72%2Y+0%

Boston Partners manages $75.6B across 707 positions as of Q4 2019. Top holdings: BAC (2.3%), BRK/B (2.2%), JPM (1.9%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.

Q4 2019 Summary

Active quarter - 58 new positions, 66 exits, 257 increased. Top move: VLO (INCREASED, conviction 65). Portfolio: $75.6B across 707 positions.

Top holdings by portfolio weight

Total AUM$76B
BAC2.34%
BRK/B2.25%
JPM1.89%
C1.69%
WFC1.45%
MPC1.36%
CI1.32%
CMCSA1.28%
MDT1.25%
CB1.20%
Other1.20%

Portfolio allocation by GICS sector

Sectors11
Financial Services23.77%
Healthcare14.31%
Unknown11.46%
Industrials9.91%
Technology9.57%
Consumer Cyclical7.08%
Communication Services6.35%
Energy4.42%
Basic Materials4.37%
Consumer Defensive3.36%
Other5.40%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Financial Services, Healthcare, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L69
Conviction51
Concentration23
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BKVBKVBKV Corporation
Q4 2024 → Q2 2026+2.5M shares+$69.4M
7Q
INVAINVAInnoviva, Inc.
Q4 2024 → Q2 2026+1.6M shares+$37.2M
7Q
KROKROKronos Worldwide Inc
Q4 2024 → Q2 2026+2.3M shares+$9.7M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used